Strategic Plan

We are pleased to present the Australia and New Zealand Sarcoma Association (ANZSA) Strategic Plan 2022-2024. This second strategic plan comes after successfully completing our Strategic Plan 2016-2021, which included 34 milestones. 

The Strategic Plan 2022-2024 will continue to expand on the work we have embarked on that is driven by high-quality patient-centred clinical trials and research to improve patient survival rates and quality of life.

Download to read the full ANZSA Strategic Plan 2022-2024.

Quality Research and Clinical Care
Funding and Governance
Professional Education
Advocacy and Awareness
  • To improve patient survival rates and outcomes
  • To build a strong research capability
  • To deepen the portfolio of high-quality patient-centred clinical trials
  • To enable patient recruitment to clinical trials
  • To contribute to the development of a universal and harmonised approach to sarcoma treatment and care
  • To improve and expand data collection and analytics
  • To develop a sarcoma registry to world-class standards
  • To deepen and further diversify funding sources
  • To encourage philanthropic activity
  • To increase government and peer-reviewed funding to sarcoma and related tumour research projects
  • To achieve a sustainable long-term funding position
  • To lead the application of contemporary governance practice, implementation of the Strategic Plan and prudent oversight of risk management
  • To attract, develop and retain the best talent to work in sarcoma
  • To recognise ANZSA members contributing to high-quality sarcoma and related tumour research
  • To foster the next generation of sarcoma clinicians and researchers
  • To foster the next generation of sarcoma clinicians and researchers
  • To establish a framework for sarcoma professional education
  • To encourage, welcome and promote active contribution from the orthopaedic sarcoma surgeon community
  • To leverage the relationship with ISOLS and other educational bodies
  • To promote sarcoma and related tumour research and clinical care to the clinical community
  • To promote sarcoma guidelines and clinical care standards to the clinical community
  • To promote sarcoma and tumour related research to the broader community
  • To raise ANZSA’s profile nationally and internationally
  • To develop a closer engagement with the New Zealand sarcoma community
  • To develop a closer relationship with the sarcoma orthopaedic surgeon community within ANZSA
  • To cultivate influence internationally through the promotion of high-quality Australia and New Zealand sarcoma and tumour related research
  • To be a strong public advocate for patients, survivors and their families
  • To more purposefully advocate to government